Oppenheimer & Co’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $589K | Sell |
66,554
-1,355
| -2% | -$12K | 0.01% | 1080 |
|
|
2025
Q1 | $532K | Buy |
67,909
+841
| +1% | +$6.59K | 0.01% | 1057 |
|
|
2024
Q4 | $705K | Buy |
67,068
+33,963
| +103% | +$357K | 0.01% | 934 |
|
|
2024
Q3 | $434K | Buy |
33,105
+2,780
| +9% | +$36.5K | 0.01% | 1092 |
|
|
2024
Q2 | $426K | Sell |
30,325
-6,770
| -18% | -$95.2K | 0.01% | 1054 |
|
|
2024
Q1 | $627K | Sell |
37,095
-816
| -2% | -$13.8K | 0.01% | 913 |
|
|
2023
Q4 | $535K | Sell |
37,911
-2,000
| -5% | -$28.2K | 0.01% | 943 |
|
|
2023
Q3 | $411K | Buy |
39,911
+5,663
| +17% | +$58.3K | 0.01% | 1016 |
|
|
2023
Q2 | $564K | Buy |
34,248
+10,890
| +47% | +$179K | 0.01% | 925 |
|
|
2023
Q1 | $214K | Buy |
+23,358
| New | +$214K | ﹤0.01% | 1239 |
|
|
2020
Q4 | – | Sell |
-27,904
| Closed | -$141K | – | 1344 |
|
|
2020
Q3 | $141K | Buy |
27,904
+5,090
| +22% | +$25.7K | ﹤0.01% | 1205 |
|
|
2020
Q2 | $184K | Buy |
+22,814
| New | +$184K | ﹤0.01% | 1137 |
|